☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Programme
GSK Initiates P-III study for RSV Candidate Vaccine Programme for Older Adults
February 17, 2021
AstraZeneca Reports Results of Roxadustat in Global Phase III Programme for Cardiovascular Safety in Patients with Chronic Kidney...
May 10, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
